Literature DB >> 33016136

Ante La Duda, Pregunta: A Social Marketing Campaign to Improve Contraceptive Access during a Public Health Emergency.

Rachel Powell1, Jackie Rosenthal2, Euna M August3, Meghan Frey4, Luis Garcia5, Turquoise Sidibe1, Zipatly Mendoza1, Lisa Romero2, Eva Lathrop6.   

Abstract

During the 2016-2017 Zika virus outbreak, preventing unintended pregnancy was recognized as a primary strategy to reduce adverse Zika-related pregnancy and birth outcomes. To increase awareness and uptake of contraceptive services provided through the Zika Contraception Access Network (Z-CAN) in Puerto Rico, a multi-strategy campaign called Ante La Duda, Pregunta (ALDP) was developed. The principal aim was to increase awareness of Z-CAN services, which included same-day access to the full range of reversible contraceptives at no cost to women living in Puerto Rico who choose to delay or avoid pregnancy during the 2016-2017 Zika virus outbreak. Using diverse strategies, ALDP increased exposure to and engagement with the campaign in order to raise awareness of Z-CAN services in Puerto Rico. The ALDP social marketing campaign played an important role in the overall Z-CAN effort. Of all the strategies utilized, Facebook appears to have reached the most people. While the importance of a social marketing campaign communicating to raise awareness and create demand has long been known, through the ALDP campaign efforts, it was shown that an effective campaign, built on formative research, can be developed and implemented rapidly in an emergency response situation without compromising on content, quality, or reach.

Entities:  

Mesh:

Year:  2020        PMID: 33016136      PMCID: PMC8019432          DOI: 10.1080/10410236.2020.1828534

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  9 in total

1.  Contraception as a Medical Countermeasure to Reduce Adverse Outcomes Associated With Zika Virus Infection in Puerto Rico: The Zika Contraception Access Network Program.

Authors:  Lisa Romero; Lisa M Koonin; Lauren B Zapata; Stacey Hurst; Zipatly Mendoza; Eva Lathrop
Journal:  Am J Public Health       Date:  2018-09       Impact factor: 9.308

2.  Community Understanding of Contraception During the Zika Virus Outbreak in Puerto Rico.

Authors:  Euna M August; Jackie Rosenthal; Ruben Torrez; Lisa Romero; Erin N Berry-Bibee; Meghan T Frey; Ricardo Torres; Brenda Rivera-García; Margaret A Honein; Denise J Jamieson; Eva Lathrop
Journal:  Health Promot Pract       Date:  2019-05-29

3.  Incidence of Zika Virus Disease by Age and Sex - Puerto Rico, November 1, 2015-October 20, 2016.

Authors:  Matthew Lozier; Laura Adams; Mitchelle Flores Febo; Jomil Torres-Aponte; Melissa Bello-Pagan; Kyle R Ryff; Jorge Munoz-Jordan; Myriam Garcia; Aidsa Rivera; Jennifer S Read; Stephen H Waterman; Tyler M Sharp; Brenda Rivera-Garcia
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-11-11       Impact factor: 17.586

4.  Knowledge of contraceptive effectiveness.

Authors:  David L Eisenberg; Gina M Secura; Tessa E Madden; Jenifer E Allsworth; Qiuhong Zhao; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2012-04-06       Impact factor: 8.661

5.  Zika Virus -10 Public Health Achievements in 2016 and Future Priorities.

Authors:  Nadia L Oussayef; Satish K Pillai; Margaret A Honein; C Ben Beard; Beth Bell; Coleen A Boyle; Lars M Eisen; Katrin Kohl; Matthew J Kuehnert; Eva Lathrop; Stacey W Martin; Rebecca Martin; Janet C McAllister; Elizabeth Pantino McClune; Paul Mead; Dana Meaney-Delman; Brett Petersen; Lyle R Petersen; Kara N D Polen; Ann M Powers; Stephen C Redd; James J Sejvar; Tyler Sharp; Julie Villanueva; Denise J Jamieson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-06       Impact factor: 17.586

6.  Updated baseline prevalence of birth defects potentially related to Zika virus infection.

Authors:  Samantha M Olson; Augustina Delaney; Abbey M Jones; Christopher P Carr; Rebecca F Liberman; Nina E Forestieri; Van T Tong; Suzanne M Gilboa; Margaret A Honein; Cynthia A Moore; Janet D Cragan
Journal:  Birth Defects Res       Date:  2019-07-02       Impact factor: 2.344

7.  Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015.

Authors:  Sheree L Boulet; Denise V D'Angelo; Brian Morrow; Lauren Zapata; Erin Berry-Bibee; Maria Rivera; Sascha Ellington; Lisa Romero; Eva Lathrop; Meghan Frey; Tanya Williams; Howard Goldberg; Lee Warner; Leslie Harrison; Shanna Cox; Karen Pazol; Wanda Barfield; Denise J Jamieson; Margaret A Honein; Charlan D Kroelinger
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-05       Impact factor: 17.586

8.  Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.

Authors:  Eva Lathrop; Stacey Hurst; Zipatly Mendoza; Lauren B Zapata; Pierina Cordero; Rachel Powell; Caitlin Green; Nilda Moreno; Denise J Jamieson; Lisa Romero
Journal:  Obstet Gynecol       Date:  2020-05       Impact factor: 7.623

9.  The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.

Authors:  Eva Lathrop; Lisa Romero; Stacey Hurst; Nabal Bracero; Lauren B Zapata; Meghan T Frey; Maria I Rivera; Erin N Berry-Bibee; Margaret A Honein; Judith Monroe; Denise J Jamieson
Journal:  Lancet Public Health       Date:  2018-01-19
  9 in total
  2 in total

Review 1.  Response strategies for promoting gender equality in public health emergencies: a rapid scoping review.

Authors:  Janina I Steinert; Caterina Alacevich; Bridget Steele; Julie Hennegan; Alexa R Yakubovich
Journal:  BMJ Open       Date:  2021-08-12       Impact factor: 3.006

2.  Impact of a Health Communication Campaign on Uptake of Contraceptive Services during the 2016-2017 Zika Virus Outbreak in Puerto Rico.

Authors:  Euna M August; Rachel Powell; Elana Morris; Lisa Romero; Lauren B Zapata; Eva Lathrop
Journal:  Health Commun       Date:  2021-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.